Abstract

Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System

Author(s): Vu Nicole T, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary

Issue: Nov/Dec 2008 - Arthritis and Immunological Diseases

Page(s): 558-564

Download in electronic PDF format for $75
  • Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System Page 1
  • Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System Page 2
  • Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System Page 3
  • Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System Page 4
  • Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System Page 5
  • Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System Page 6
  • Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System Page 7

Abstract

The objective of this study was to determine the stability of metronidazole benzoate suspension in SyrSpend SF One-Step Suspension System. The studied samples were packaged in 60-mL amber plastic prescription bottles, which were stored protected from light under controlled environmental conditions for a period of 360 days. Stability of metronidazole benzoate suspension in SyrSpend SF was assessed based on retention of initial color or appearance, pH of suspension, and recovery of metronidazole benzoate from the packaged product. Duplicate samples were evaluated at each predefined time interval. An assay method by high performance liquid chromatography was validated for its specificity and stability-indicating characteristics through a forced-degradation study, and was used in metronidazole benzoate assay. Metronidazole benzoate in SyrSpend SF retained its normal appearance of an opaque suspension, with acceptable pH values ranging from 4.43 to 4.53 (range 4.45 ± 0.5). Recovery of metronidazole benzoate at sub

Related Keywords

  • stability
  • metronidazole
  • antibiotics
  • antimicrobial agents
  • commercial suspension system
  • storage

Related Categories

  • EXCIPIENTS
  • PEER-REVIEWED
  • STABILITIES, COMPATIBILITIES
  • INFECTIOUS DISEASE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2008
Pg. 558-564
Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System
Author(s): Vu Nicole T, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
Jul/Aug 2018
Pg. 320
Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 77-82
Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets
Author(s): Jarouche Marian, Ibrahim Martha, Pearson Jarryd, Low Mitchell, Rowe James
Mar/Apr 2021
Pg. 169-175
Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt
Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
May/Jun 2015
Pg. 248-251
Stability of Metronidazole Suspensions
Author(s): Donnelly Ronald F, Ying James
Jul/Aug 2020
Pg. 327-336
Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4
Author(s): Espana B, Joseph-Tornabène F, Jaquet Cécile, Perrot S, Prouillac C
Jan/Feb 2021
Pg. 47
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 24-28
Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension
Author(s): McElhiney Linda F
Sep/Oct 2015
Pg. 432-436
In-use Stability of Ceftaroline Fosamil in Elastomeric Home Infusion Systems and MINI-BAG Plus Containers
Author(s): Bhattacharya Sisir, Parekh Satish, Dedhiya Mahendra
Jul/Aug 2025
Pg. 319-327
Antimicrobial Effectiveness and Physicochemical Stability of Compounded Psychiatric and Neurological Drug Suspensions in SyrSpend® SF PH4
Author(s): Kegele Carolina Schettino, Dijkers Eli, Polonini Hudson
Mar/Apr 2002
Pg. 152-154
Stability of Gentamicin Sulfate and Tobramycin Sulfate in AutoDose Infusion System Bags
Author(s): Xu Quanyun A, Trissel Lawrence A, Saenz Christopher A, Ingram Delshalonda S
Jul/Aug 2001
Pg. 310-312
Wetting and/or Solubilizing Agents, Featured Excipient:
Author(s): Allen Loyd V Jr
Mar/Apr 2008
Pg. 170-173
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Author(s): Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
Sep/Oct 2015
Pg. 420-427
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF
Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul
Jul/Aug 2013
Pg. 344-346
Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry
Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul A
Jul/Aug 2017
Pg. 322-329
Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox)
Author(s): Ip Kendice, Carvalho Maria, Shan Ashley, Banov Daniel
Sep/Oct 2003
Pg. 389-393
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Author(s): Alexander Kenneth S, Thyangarajapuram N
Jan/Feb 2001
Pg. 46
Metronidazole Benzoate 400-mg/5-mL Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 2001
Pg. 153-156
Stability and Dissolution of Lozenge and Emulsion Formulations of Metronidazole Benzoate
Author(s): Fan Bin, Stewart James T, White Catherine A
Sep/Oct 2014
Pg. 427-431
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition
Author(s): Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard